Cargando…
Short-Term Prognostic Efficacy of mGPS and LCS in Patients With Acute Heart Failure
AIM: Systemic inflammation plays an important role in the occurrence and development of acute heart failure. The modified Glasgow Prognostic Score (mGPS) and “lymphocyte C-reactive protein score” (LCS) are used to assess the inflammation levels in cancer patients. The purpose of this study was to as...
Autores principales: | Wang, Jing, Xie, Ling, Lyu, Ping, Zhou, Feng, Cai, Hong-Li, Qi, Rong-Xing, Zhang, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295910/ https://www.ncbi.nlm.nih.gov/pubmed/35865381 http://dx.doi.org/10.3389/fcvm.2022.944424 |
Ejemplares similares
-
High-sensitivity modified Glasgow prognostic score (HS-mGPS) Is superior to the mGPS in esophageal cancer patients treated with chemoradiotherapy
por: Chen, Peng, et al.
Publicado: (2017) -
A comprehensive analysis of Glasgow Prognostic Score (GPS)/the modified Glasgow Prognostic Score (mGPS) on immune checkpoint inhibitor efficacy among patients with advanced cancer
por: Zhang, Yongchao, et al.
Publicado: (2022) -
An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study
por: Proctor, M J, et al.
Publicado: (2011) -
The Relationship between ECOG-PS, mGPS, BMI/WL Grade and Body Composition and Physical Function in Patients with Advanced Cancer
por: Dolan, Ross D., et al.
Publicado: (2020) -
Prognostic value of post-discharge depression in patients recently hospitalized with acute heart failure
por: Li, Junlei, et al.
Publicado: (2022)